ReviewMaterials today. Bio2025
Micro/nanorobots in antimicrobial therapy: Addressing challenges of antibiotic resistance.
Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Use of Micro/Nanorobots In Vivo for the Eradication of Bacterial Biofilm: A Review of Challenges and Strategies.Nanomaterials (Basel, Switzerland) · 2026Review
- Nanorobotic Approaches Against Multidrug-Resistant Infections: Design, Principle, Mechanistic Innovation, Translational Challenges and Biomedical Applications.Molecules (Basel, Switzerland) · 2026Review
- Micro/nanorobotics for sepsis diagnosis and therapy: a frontier in precision medicine.Theranostics · 2026Review
- Emerging Multimodal Strategies for Bacterial Biofilm Eradication: A Comprehensive Review.Microorganisms · 2025Review
- Micro/Nanorobots in Wound Healing: Bridging the Gap from Concept to Clinical Translation.International journal of nanomedicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotic resistance has emerged as a critical global health challenge, particularly when bacteria form biofilms that render conventional antimicrobial treatments markedly less effective. Bacteria residing within biofilm exhibit increased resistance to antimicrobial agents and host immune defenses, complicating treatment and contributing to recurrent infections. Antimicrobial micro- and nanorobots (MNRs) have garnered significant attention as a promising strategy to combat drug-resistant bacteria and biofilms, owing to their exceptional motility, precise targeting, and improved penetration capabilities. Despite their potential, challenges related to biocompatibility, imaging integration, and clinical translation remain unresolved. This review summarizes the latest developments in the therapy of micro/nanorobots for antimicrobial therapy, emphasizing innovative strategies for bacterial eradication and biofilm disruption while addressing the technical hurdles and exploring future research directions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.